Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Peripheral × endostar protein × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 17 Nasopharyngeal Carcinoma 7 Lung Neoplasms 7 Uterine Cervical Neoplasms 3 Esophageal Squamous Cell Carcinoma 3 Colorectal Neoplasms 3 Breast Neoplasms 3 Sarcoma 2 Osteosarcoma 2 Nasopharyngeal Neoplasms 2 Melanoma 2 Lymphoma, T-Cell 2 Unresectable Non-small Cell Lung Cancer 1 Stomach Neoplasms 1 Recurrence 1 Radiation Injuries 1 Quality of Life 1 Pleural Effusion, Malignant 1 Neuroblastoma 1 Lymphoma, T-Cell, Peripheral 1 Head and Neck Neoplasms 1 Gastrointestinal Neoplasms 1 Esophageal Neoplasms 1 Esophageal 1 Brain Neoplasms 1 Bone Neoplasms 1 Advanced Pancreatic Cancer 1 Advanced Gastric Cancer 1 Adenocarcinoma of Lung 1

Interventions

Cyclophosphamide 30 N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide 24 Prednisone 22 Vincristine 18 romidepsin 17 Doxorubicin 17 Etoposide 16 Gemcitabine 15 10-propargyl-10-deazaaminopterin 15 fludarabine phosphate 12 Whole-Body Irradiation 11 Lenalidomide 11 Peripheral Blood Stem Cell Transplantation 10 Brentuximab Vedotin 10 Azacitidine 10 Mycophenolic Acid 9 Bortezomib 9 Cyclosporine 8 Alemtuzumab 8 fludarabine 7 Dexamethasone 7 belinostat 5 Rituximab 5 Granulocyte Colony-Stimulating Factor 5 Cytarabine 5 Bendamustine Hydrochloride 5 selinexor 4 darinaparsin 4 Vorinostat 4 VAP-cyclo protocol 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00974324 2010-09-15

PTCL

Fudan University

Phase 2 Unknown

Lymphoma, T-Cell, Lymphoma, T-Cell, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon ⚡